Table 1. Patient demographic and complete Rockall score, important comorbidities and medication in the whole cohort, monotherapy and salvage therapy subgroups. NSAID: non-steroidal anti-inflammatory drugs.
| Total cohort (n = 52) | Monotherapy (n = 23) | Salvage therapy (n = 29) | |
| Age, y, median (range) | 69 (32 – 92) | 68 (32 – 92) | 69 (36 – 89) |
| Sex (m/f) | 31/21 | 16/7 | 15/14 |
| Platelet inhibition, n (%) | 13 (25) | 9 (39.1) | 4 (13.8) |
| Anticoagulation, n (%) | 13 (25) | 3 (13) | 10 (34.5) |
| NSAID, n (%) | 8 (15.4) | 1 (4.3) | 7 (24.1) |
| Glucocorticoid, n (%) | 1 (1.9) | 0 | 1 (3.4) |
| Malignancy, n (%) | 16 (30.8) | 4 (17.4) | 12 (41.4) |
| Atrial fibrillation, n (%) | 8 (15.4) | 0 | 8 (27.6) |
| Coronary heart disease, n (%) | 6 (11.5) | 3 (13) | 3 (10.3) |
| Complete Rockall score, median (range) | 7 (3 – 10) | 7 (5 – 9) | 7 (3 – 10) |
|
25 (48.1) | 11 (47.8) | 14 (48.3) |
|
27 (51.9) | 12 (52.2) | 15 (51.7) |